Hepatitis Health Center

News and Features Related to Hepatitis

51. FDA Approves New Hepatitis B Treatment
    

    March 30, 2005 -- The FDA has approved Baraclude (entecavir) to treat chronic hepatitis B hepatitis B in adults. Baraclude slows the progression of chronic hepatitis B by interfering with the virus that causes the disease, says the FDA. Nearly 1.25 million people in the U.S. are infected with the he

    Read Full Article
52. Vaccine Stops Hepatitis B for 15 Years
    

    Feb. 28, 2005 -- The hepatitis B vaccine works for at least 15 years -- longer than once thought. The vaccine thwarts the virus that causes hepatitis B, a liver disease that can lead to liver cirrhosis or cancer . Most countries include the vaccine in their infant immunization programs. It's given i

    Read Full Article
53. Hepatitis C Ups Lymphoma, Bone Marrow Cancer
    

    Feb. 23, 2005 - Hepatitis C infection ups a person's risk of non-Hodgkin's lymphoma and multiple myeloma, a Swedish study suggests. An odd finding piqued the interest of Ann-Sofi Duberg, MD, of Örebro University Hospital, Örebro, Sweden, and colleagues. Four otherwise healthy young Swedes came down

    Read Full Article
54. Hepatitis B Vaccine in Potatoes Shows Promise
    

    Feb. 14, 2005 -- Could potatoes with a built-in hepatitis B vaccine help save the lives of millions of people worldwide? It might work, judging by a preliminary study from Yasmin Thanavala, PhD, and colleagues. Thanavala works in the immunology department at Roswell Park Cancer Institute in Buffalo,

    Read Full Article
55. Interferon Alone Effective for Hepatitis B
    

    Jan. 6, 2004 - Treating chronic hepatitis B remains a challenge, but new research shows that a long-acting version of an old hepatitis drug works just as well as a combination approach. A year of treatment with a long-acting interferon called Peg-Intron led to a sustained response in just over a thi

    Read Full Article
56. Hepatitis B Declining Among Youths
    

    Nov. 5, 2004 -- The number of hepatitis B cases among children and adolescents has declined by 89% since 1991, according to a new federal report. The CDC study shows that the number of hepatitis B cases reported among children and teens aged 19 and under has dropped from about three per 100,000 in 1

    Read Full Article
57. New Hepatitis C Treatment Shows Promise
    

    Nov. 2, 2004 -- Findings from a highly anticipated study offer hope to people with hepatitis C who do not respond to standard antiviral therapy. Life-threatening complications of hepatitis C-related liver disease were cut in half among patients treated long term with low-dose PEG-Intron. The trial,

    Read Full Article
58. Hepatitis C Treatment Works in HIV Patients
    

    July 28, 2004 -- People infected with both hepatitis C and HIV can be safely and effectively treated with current hepatitis C therapies without compromising their HIV treatment, according to a new study. Researchers say about a third of HIV-positive people are also infected with the hepatitis C viru

    Read Full Article
59. Response to Hep C Treatment Worse for Blacks
    

    May 26, 2004 -- New research confirms that blacks are much less likely than whites to respond to hepatitis C treatment. But investigators say it is not because they have a higher incidence of infection with a hard-to-treat form of the virus. In the Duke University study, roughly half of the non-Hisp

    Read Full Article
60. New Drugs Show Promise in Hepatitis C Fight
    

    May 18, 2004 -- With current hepatitis C treatments, about half of all patients can now be cured -- that's great if you're in that half. Now, two novel therapies -- one conventional, one unconventional -- show promise for treating those people for whom standard medications fail. "About one in four p

    Read Full Article